# Aptargroup, Inc.: financial statements, quarterly

ATR · NYSE · CIK 896622 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/atr.md) · [Financials](/companies/atr/financials.md) · [Filings](/companies/atr/filings.md) · [Insiders](/companies/atr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/atr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [838 d](/filings/0000896622-26-000007.md) | [915](/filings/0000896622-25-000014.md) | [910](/filings/0000896622-25-000028.md) | [909](/filings/0000896622-25-000033.md) | [848 d](/filings/0000896622-26-000007.md) | [887](/filings/0000896622-26-000092.md) | [966](/filings/0000896622-26-000168.md) | [961](/filings/0000896622-26-000190.md) | [963 d](/filings/0000896622-26-000007.md) | [983](/filings/0000896622-26-000092.md) | [1,027](/filings/0000896622-26-000168.md) | [1,019](/filings/0000896622-26-000190.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [84.2 d](/filings/0000896622-26-000007.md) | [112](/filings/0000896622-25-000014.md) | [126](/filings/0000896622-25-000028.md) | [138](/filings/0000896622-25-000033.md) | [120 d](/filings/0000896622-26-000007.md) | [113](/filings/0000896622-26-000092.md) | [144](/filings/0000896622-26-000168.md) | [137](/filings/0000896622-26-000190.md) | [106 d](/filings/0000896622-26-000007.md) | [107](/filings/0000896622-26-000092.md) | [127](/filings/0000896622-26-000168.md) | [135](/filings/0000896622-26-000190.md) |
| Interest expense | $m | [10.5 d](/filings/0000896622-24-000010.md) | [10.2](/filings/0000896622-24-000021.md) | [10.1](/filings/0000896622-25-000028.md) | [12.3](/filings/0000896622-25-000033.md) | [11.4 d](/filings/0000896622-26-000007.md) | [11.4](/filings/0000896622-26-000092.md) | [10.9](/filings/0000896622-26-000168.md) | [13.5](/filings/0000896622-26-000190.md) | [17.0 d](/filings/0000896622-26-000007.md) | [16.9](/filings/0000896622-26-000092.md) | [16.0](/filings/0000896622-26-000168.md) | [15.8](/filings/0000896622-26-000190.md) |
| Income tax | $m | [18.4 d](/filings/0000896622-26-000007.md) | [21.4](/filings/0000896622-25-000014.md) | [27.8](/filings/0000896622-25-000028.md) | [31.2](/filings/0000896622-25-000033.md) | [15.2 d](/filings/0000896622-26-000007.md) | [27.4](/filings/0000896622-26-000092.md) | [28.0](/filings/0000896622-26-000168.md) | [26.3](/filings/0000896622-26-000190.md) | [17.3 d](/filings/0000896622-26-000007.md) | [21.0](/filings/0000896622-26-000092.md) | [27.0](/filings/0000896622-26-000168.md) | [27.5](/filings/0000896622-26-000190.md) |
| Net income | $m | [62.4 d](/filings/0000896622-26-000007.md) | [83.1](/filings/0000896622-25-000014.md) | [90.5](/filings/0000896622-25-000028.md) | [100](/filings/0000896622-25-000033.md) | [101 d](/filings/0000896622-26-000007.md) | [78.8](/filings/0000896622-26-000092.md) | [112](/filings/0000896622-26-000168.md) | [128](/filings/0000896622-26-000190.md) | [74.3 d](/filings/0000896622-26-000007.md) | [72.7](/filings/0000896622-26-000092.md) | [87.6](/filings/0000896622-26-000168.md) | [32.6](/filings/0000896622-26-000190.md) |
| Diluted EPS | $ per share | not reported | [1.23](/filings/0000896622-25-000014.md) | [1.34](/filings/0000896622-25-000028.md) | [1.48](/filings/0000896622-25-000033.md) | not reported | [1.17](/filings/0000896622-26-000092.md) | [1.67](/filings/0000896622-26-000168.md) | [1.92](/filings/0000896622-26-000190.md) | not reported | [1.12](/filings/0000896622-26-000092.md) | [1.36](/filings/0000896622-26-000168.md) | [0.51](/filings/0000896622-26-000190.md) |
| Basic EPS | $ per share | not reported | [1.26](/filings/0000896622-25-000014.md) | [1.36](/filings/0000896622-25-000028.md) | [1.51](/filings/0000896622-25-000033.md) | not reported | [1.19](/filings/0000896622-26-000092.md) | [1.69](/filings/0000896622-26-000168.md) | [1.95](/filings/0000896622-26-000190.md) | not reported | [1.13](/filings/0000896622-26-000092.md) | [1.38](/filings/0000896622-26-000168.md) | [0.51](/filings/0000896622-26-000190.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [224](/filings/0000896622-26-000007.md) | [200](/filings/0000896622-24-000021.md) | [221](/filings/0000896622-24-000034.md) | [326](/filings/0000896622-24-000040.md) | [224](/filings/0000896622-26-000007.md) | [126](/filings/0000896622-26-000092.md) | [162](/filings/0000896622-26-000168.md) | [257](/filings/0000896622-26-000190.md) | [402](/filings/0000896622-26-000190.md) | [223](/filings/0000896622-26-000092.md) | [190](/filings/0000896622-26-000168.md) | [204](/filings/0000896622-26-000190.md) |
| Current assets | $m | [1,549](/filings/0000896622-25-000007.md) | [1,560](/filings/0000896622-24-000021.md) | [1,594](/filings/0000896622-24-000034.md) | [1,666](/filings/0000896622-24-000040.md) | [1,478](/filings/0000896622-26-000007.md) | [1,512](/filings/0000896622-25-000014.md) | [1,663](/filings/0000896622-25-000028.md) | [1,784](/filings/0000896622-25-000033.md) | [1,894](/filings/0000896622-26-000190.md) | [1,768](/filings/0000896622-26-000092.md) | [1,835](/filings/0000896622-26-000168.md) | [1,837](/filings/0000896622-26-000190.md) |
| Total assets | $m | [4,452](/filings/0000896622-26-000007.md) | [4,437](/filings/0000896622-24-000021.md) | [4,453](/filings/0000896622-24-000034.md) | [4,625](/filings/0000896622-24-000040.md) | [4,432](/filings/0000896622-26-000007.md) | [4,527](/filings/0000896622-25-000014.md) | [4,865](/filings/0000896622-25-000028.md) | [5,101](/filings/0000896622-25-000033.md) | [5,253](/filings/0000896622-26-000190.md) | [5,098](/filings/0000896622-26-000092.md) | [5,133](/filings/0000896622-26-000168.md) | [5,112](/filings/0000896622-26-000190.md) |
| Current liabilities | $m | [1,251](/filings/0000896622-25-000007.md) | [1,196](/filings/0000896622-24-000021.md) | [1,168](/filings/0000896622-24-000034.md) | [1,027](/filings/0000896622-24-000040.md) | [1,068](/filings/0000896622-26-000007.md) | [1,208](/filings/0000896622-25-000014.md) | [1,369](/filings/0000896622-25-000028.md) | [1,499](/filings/0000896622-25-000033.md) | [1,166](/filings/0000896622-26-000190.md) | [1,063](/filings/0000896622-26-000092.md) | [1,137](/filings/0000896622-26-000168.md) | [1,223](/filings/0000896622-26-000190.md) |
| Short-term borrowings | $m | [81.8](/filings/0000896622-25-000007.md) | [164](/filings/0000896622-24-000021.md) | [136](/filings/0000896622-24-000034.md) | [223](/filings/0000896622-24-000040.md) | [176](/filings/0000896622-26-000007.md) | [159](/filings/0000896622-25-000014.md) | [265](/filings/0000896622-25-000028.md) | [368](/filings/0000896622-25-000033.md) | [184](/filings/0000896622-26-000190.md) | [189](/filings/0000896622-26-000092.md) | [218](/filings/0000896622-26-000168.md) | [229](/filings/0000896622-26-000190.md) |
| Shareholders' equity | $m | [2,307](/filings/0000896622-25-000007.md) | [2,349](/filings/0000896622-24-000021.md) | [2,396](/filings/0000896622-24-000034.md) | [2,539](/filings/0000896622-24-000040.md) | [2,472](/filings/0000896622-26-000007.md) | [2,538](/filings/0000896622-25-000014.md) | [2,700](/filings/0000896622-25-000028.md) | [2,770](/filings/0000896622-25-000033.md) | [2,668](/filings/0000896622-26-000190.md) | [2,629](/filings/0000896622-26-000092.md) | [2,628](/filings/0000896622-26-000168.md) | [2,614](/filings/0000896622-26-000190.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [220 d](/filings/0000896622-26-000007.md) | [92.3](/filings/0000896622-25-000014.md) | [144 d](/filings/0000896622-25-000028.md) | [229 d](/filings/0000896622-25-000033.md) | [178 d](/filings/0000896622-26-000007.md) | [82.7](/filings/0000896622-26-000092.md) | [126 d](/filings/0000896622-26-000168.md) | [178 d](/filings/0000896622-26-000190.md) | [184 d](/filings/0000896622-26-000007.md) | [119](/filings/0000896622-26-000092.md) | [103 d](/filings/0000896622-26-000168.md) | [168 d](/filings/0000896622-26-000190.md) |
| Capital expenditure | $m | [81.1 d](/filings/0000896622-26-000007.md) | [75.7](/filings/0000896622-25-000014.md) | [68.2 d](/filings/0000896622-25-000028.md) | [66.6 d](/filings/0000896622-25-000033.md) | [66.1 d](/filings/0000896622-26-000007.md) | [56.9](/filings/0000896622-26-000092.md) | [63.4 d](/filings/0000896622-26-000168.md) | [63.3 d](/filings/0000896622-26-000190.md) | [86.8 d](/filings/0000896622-26-000007.md) | [65.4](/filings/0000896622-26-000092.md) | [57.6 d](/filings/0000896622-26-000168.md) | [69.0 d](/filings/0000896622-26-000190.md) |
| Dividends paid | $m | [27.0 d](/filings/0000896622-26-000007.md) | [27.1](/filings/0000896622-25-000014.md) | [27.2 d](/filings/0000896622-25-000028.md) | [29.9 d](/filings/0000896622-25-000033.md) | [29.9 d](/filings/0000896622-26-000007.md) | [29.9](/filings/0000896622-26-000092.md) | [29.7 d](/filings/0000896622-26-000168.md) | [29.6 d](/filings/0000896622-26-000190.md) | [31.5 d](/filings/0000896622-26-000007.md) | [30.9](/filings/0000896622-26-000092.md) | [30.6 d](/filings/0000896622-26-000168.md) | [30.5 d](/filings/0000896622-26-000190.md) |
| Share repurchases | $m | [10.3 d](/filings/0000896622-26-000007.md) | [12.1](/filings/0000896622-25-000014.md) | [5.1 d](/filings/0000896622-25-000028.md) | [14.2 d](/filings/0000896622-25-000033.md) | [37.3 d](/filings/0000896622-26-000007.md) | [80.0](/filings/0000896622-26-000092.md) | [70.0 d](/filings/0000896622-26-000168.md) | [40.0 d](/filings/0000896622-26-000190.md) | [175 d](/filings/0000896622-26-000007.md) | [100.0](/filings/0000896622-26-000092.md) | [50.0 d](/filings/0000896622-26-000168.md) | [30.0 d](/filings/0000896622-26-000190.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [66.7](/filings/0000896622-24-000021.md) | [66.9](/filings/0000896622-24-000034.md) | [67.0](/filings/0000896622-24-000040.md) | [67.4](/filings/0000896622-25-000014.md) | [67.6](/filings/0000896622-25-000028.md) | [67.7](/filings/0000896622-25-000033.md) | [67.5](/filings/0000896622-26-000092.md) | [67.0](/filings/0000896622-26-000168.md) | [66.6](/filings/0000896622-26-000190.md) | [64.8](/filings/0000896622-26-000092.md) | [64.2](/filings/0000896622-26-000168.md) | [64.1](/filings/0000896622-26-000190.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 63,388,980 at 2026-10-26, from the cover of the [10-Q filed 2026-10-30](/filings/0000896622-26-000190.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 10:24 ET. No prices; not investment advice.